Assoc. Prof. GAMZE BORA AKOĞLU

Publication Network

Articles 25

1. Gene Targeted Therapies for Neurodegenerative Disorders: Strategies and Implications in ALS and SMA

Yesbek Kaymaz A., BORA AKOĞLU G., Erdem Yurter H., Grunseich C.

Genes , vol.17, no.4, 2026 (SCI-Expanded, Scopus)

2. **Histone deacetylase inhibitory properties of metabolites from leaves of Quercus pontica K. Koch and its metabolites**

RENDA G., Sevgi S., Soral M., BORA AKOĞLU G., SARI S., Cetin O., et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH , vol.35, no.6, pp.1616-1627, 2025 (SCI-Expanded, Scopus) Sustainable Development

3. Split but merge: Golgi fragmentation in physiological and pathological conditions.

Zobaroğlu-Özer P., Bora-Akoğlu G.

Molecular biology reports , vol.51, no.1, pp.214, 2024 (SCI-Expanded, Scopus)

4. Membraneless Bodies of Cells Formed by Liquid-Liquid Phase Separation: Literature Review

GUMUS D., BORA G.

Kocaeli Tıp Dergisi , vol.12, no.1, pp.75-88, 2023 (TRDizin)

5. Alterations in insulin-like growth factor system in spinal muscular atrophy

YEŞBEK KAYMAZ A., Bal S. K., Bora G., TALİM B., Ozon A., ALİKAŞİFOĞLU A., et al.

MUSCLE & NERVE , vol.66, no.5, pp.631-638, 2022 (SCI-Expanded, Scopus)

6. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition

Cetin O., SARI S., Erdem-Yurter H., BORA G.

DRUG DEVELOPMENT RESEARCH , vol.83, no.4, pp.993-1002, 2022 (SCI-Expanded, Scopus)

7. SMN loss dysregulates microtubule-associated proteins in spinal muscular atrophy model

Ozer P. Z., Koyunoglu D., SON Ç. D., Erdem-Yurter H., BORA G.

MOLECULAR AND CELLULAR NEUROSCIENCE , vol.120, 2022 (SCI-Expanded, Scopus)

8. Organelle Positioning in Neurons and Skeletal Muscle Cells

AKSU MENGEŞ E., KURAL MANGIT E., Bekircan-Kurt C. E., BORA G.

GAZI MEDICAL JOURNAL , vol.32, pp.341-347, 2021 (ESCI, Scopus)

9. Reshaping cytoskeleton: different acts of modulatory compounds

Zobaroglu P., BORA G.

ISTANBUL JOURNAL OF PHARMACY , vol.50, no.3, pp.304-311, 2020 (ESCI)

10. Microtubule-associated protein 1B dysregulates microtubule dynamics and neuronal mitochondrial transport in spinal muscular atrophy

Bora G., Hensel N., Rademacher S., Koyunoğlu D., Sunguroğlu M., Aksu-Mengeş E., et al.

HUMAN MOLECULAR GENETICS , vol.29, no.24, pp.3935-3944, 2020 (SCI-Expanded, Scopus) Sustainable Development

11. MAP1B upregulation and its involvement of microtubule stability in spinal muscular atrophy

BORA G., Hensel N., Rademacher S., Koyunoglu D., Sunguroglu M., Aksu-Menges E., et al.

FEBS OPEN BIO , vol.9, pp.32, 2019 (SCI-Expanded, Scopus)

12. Investigations of Microtubule-associated Protein 2 Gene Expression in Spinal Muscular Atrophy

BORA G., SUCULARLI C., Hensel N., Claus P., Yurter H. E.

JOURNAL OF PEDIATRIC RESEARCH , vol.6, no.2, pp.148-154, 2019 (ESCI, TRDizin)

13. Class I histone deacetylase inhibition by aryl butenoic acid derivatives: In silico and in vitro studies

BORA G., SARI S., Taskor G., DALKARA S., Erdem-Yurter H.

JOURNAL OF RESEARCH IN PHARMACY , vol.23, no.5, pp.952-959, 2019 (ESCI, Scopus, TRDizin)

14. Effects of Arm Cycling Exercise in Spinal Muscular Atrophy Type II Patients: A Pilot Study.

BORA G., Subasi-Yildiz Ş., Yesbek-Kaymaz A., BULUT N., Alemdaroglu I., Tunca-Yilmaz O., et al.

Journal of child neurology , vol.33, no.3, pp.209-215, 2018 (SCI-Expanded, Scopus)

15. Recent therapeutic developments in spinal muscular atrophy

BORA G., YEŞBEK KAYMAZ A., Bekircan Kurt C. E., HALİLOĞLU V. G., TOPALOĞLU H. A., Erdem Yurter H., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.2, pp.203-211, 2018 (SCI-Expanded, Scopus, TRDizin)

16. Metalloprotease-mediated cleavage of PlexinD1 and its sequestration to actin rods in the motoneuron disease spinal muscular atrophy (SMA)

Rademacher S., Verheijen B. M., Hensel N., Peters M., BORA G., Brandes G., et al.

HUMAN MOLECULAR GENETICS , vol.26, no.20, pp.3946-3959, 2017 (SCI-Expanded, Scopus)

17. Effects of flavonoid quercetin on survival of motor neuron gene expression.

Uzunalli G., Bora-Tatar G., Dayangac-Erden D., Erdem-Yurter H.

Cell biology international , vol.39, no.3, pp.350-4, 2015 (SCI-Expanded, Scopus)

18. Investigations of Curcumin and Resveratrol on Neurite Outgrowth: Perspectives on Spinal Muscular Atrophy

Bora-Tatar G., Erdem-Yurter H.

BIOMED RESEARCH INTERNATIONAL , 2014 (SCI-Expanded, Scopus)

19. Carboxylic acid derivatives of histone deacetylase inhibitors induce full length SMN2 transcripts: a promising target for spinal muscular atrophy therapeutics.

Dayangac-Erden D., Bora-Tatar G., DALKARA S., DEMİR A. G., Erdem-Yurter H.

Archives of medical science : AMS , vol.7, no.2, pp.230-4, 2011 (SCI-Expanded, Scopus)

20. Evaluation of the effects of vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in postmenopausal women.

Tanriover M., Tatar G., Uluturk T. D., Erden D. D., Tanriover A., Kilicarslan A., et al.

Clinical rheumatology , vol.29, no.11, pp.1285-93, 2010 (SCI-Expanded, Scopus)

21. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.

Bora-Tatar G., Dayangac-Erden D., DEMİR A. G., DALKARA S., Yelekci K., Erdem-Yurter H.

Bioorganic & medicinal chemistry , vol.17, no.14, pp.5219-28, 2009 (SCI-Expanded, Scopus)

22. Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy

Dayangac-Erden D., Bora G., Ayhan P., Kocaefe C., DALKARA S., Yelekci K., et al.

CHEMICAL BIOLOGY & DRUG DESIGN , vol.73, no.3, pp.355-364, 2009 (SCI-Expanded, Scopus)

23. Vitamin D receptor gene polymorphisms in Turkish children with vitamin D deficient rickets

BORA G., Oezkan B., Dayangac-Erden D., Erdem-Yurter H., COŞKUN T.

TURKISH JOURNAL OF PEDIATRICS , vol.50, no.1, pp.30-33, 2008 (SCI-Expanded, Scopus)

24. MEDI 333-Histone deacetylase inhibition activity of resveratrol and its analogs

Dayangac-Erden D., Ayhan P., BORA G., Yelekci K., DALKARA S., DEMİR A. G., et al.

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , vol.234, 2007 (SCI-Expanded)

25. COMP 297-Experimental and molecular docking simulation studies of Histone deacetylases (HDACs) enzyme inhibitors

Yelekci K., BORA G., Dayangac-Erden D., Ayhan P., DALKARA S., DEMİR A. G., et al.

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , vol.234, 2007 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 49

1. Dysregulations of microtubule plus end proteins in an in vitro spinal muscular atrophy model

ZOBAROĞLU ÖZER P., AYDIN Y., TUNÇBAĞ N., SON Ç. D., YURTER H., BORA AKOĞLU G.

48th FEBS Congress, Mining biochemistry for human health and well-being, Milan, Italy, 29 June - 03 July 2024, (Summary Text)

2. Alterations of microtubule plus end tracking protein p150Glued in an in vitro Spinal muscular atrophy model

ZOBAROĞLU ÖZER P., AYDIN Y., TUNÇBAĞ N., SON Ç. D., YURTER H., BORA AKOĞLU G.

4th Scientific International congress on SMA, Ghent, Belgium, 14 - 16 March 2024, (Summary Text)

3. Microtubule plus end tracking protein p150glued is dysregulated in spinal muscular atrophy.

ZOBAROĞLU ÖZER P., AYDIN Y., TUNÇBAĞ N., SON Ç. D., YURTER H., BORA AKOĞLU G.

TuPA 2023, Uluslararası Proteomik Kongresi, 5. Ulusal Proteomik Kongres, 13 - 14 October 2023, (Summary Text)

4. Investigation of the interaction of SMN with microtubule-associated proteins.

Aydın Y., Tunçbağ N., Yurter H., Bora G.

15th International Symposium on Health Informatics and Bioinformatics (HIBIT), Mersin, Turkey, 20 - 21 October 2022, (Unpublished)

5. Alpha-Tubulin Acetylation Loss Effects Golgi Morphology In SMA

Zobaroğlu Özer P., Yurter H., Bora G.

TuPA 2022 Uluslararası Proteomik Kongresi, 4. Ulusal Proteomik Kongresi, İzmir, Turkey, 14 - 15 October 2022, pp.33, (Summary Text)

6. Alterations of alpha tubulin acetylation and Golgi morphology in spinal muscular atrophy

Zobaroğlu Özer P., Yurter H., Bora G.

5th Proteomics in cell biology and disease mechanism, Cambridge, England, 10 - 12 October 2022, pp.34, (Summary Text)

7. Dysregulation of alpha-tubulin acetylation in an in vitro and in vivo SMA models.

Zobaroğlu Özer P., Gözüböyük M., Emecan G., Yurter H., Bora G.

8th International Congress of Molecular Biology Association of Turkey (Molbiyokon)., İstanbul, Turkey, 9 - 12 June 2022, pp.54, (Summary Text)

8. SMN deficiency alters end-binding and microtubule-associated protein levels in Spinal muscular atrophy

Zobaroğlu Özer P., Koyunoğlu D., Yurter H., Bora G.

Cell Bio Virtual, Online ASCB/EMBO Meeting,, Alabama, United States Of America, 1 - 10 December 2021, pp.496-497, (Summary Text)

9. Is microtubule stability altered in spinal muscular atrophy patient fibroblast cells?

Zobaroğlu P., Bora G., Yurter H.

Microtubules: From Atoms to Complex Systems, EMBO/EMBL Virtual Symposium, , 3 - 06 June 2020, (Unpublished)

10. Levels of Microtubule Associated Proteins in an in vitro SMA Model

Zobaroğlu Özer P., Yurter H., Bora G.

SMA Research and Clinical Care Meeting, Alabama, United States Of America, 9 - 11 June 2021, (Unpublished)

11. Levels of Microtubule Associated Proteins in an in vitro SMA Model.

Zobaroğlu P., Bora G., Yurter H.

SMA Research and Clinical Care Meeting, 9 - 11 June 2021, (Unpublished)

12. Investigation of Compounds Inducing Alpha Tubulin Acetylation by Drug Repurposing Approach.14th UK Annual Neuromuscular Translational Research Conference

Çetin Ö., Sarı S., Yurter H., Bora G.

New therapies in Neuromuscular Diseases, London, United Kingdom, 25 - 26 March 2021, (Unpublished)

13. Investigations of Microtubule Stability in Spinal Muscular Atrophy Patient Fibroblasts.

Zobaroğlu P., Bora G., Yurter H.

Online ASCB/EMBO Meeting., 2 - 16 December 2020, (Unpublished)

14. In vitro SMA Modelinde Mikrotübül Pozitif Uç Proteinlerinin Araştırılması

Bora G., Yurter H., Son Ç. D., Koyunoğlu D.

3. Nöromüsküler hastalıklar kongresi, İzmir, Turkey, 1 - 03 November 2020, (Unpublished)

15. Spinal Müsküler Atrofi Patomekanizmasında MAP1B Disregülasyonunun Rolü.

Bora G., Rademacher S., Hensel N., Yurter H.

1. Ulusal Nöromüsküler Hastalıklar Kongresi, Ankara, Turkey, 18 - 20 May 2017, (Unpublished)

16. Contribution of altered microtubule-regulatory proteins to SMA pathomechanisms

Bora G., Koyunoğlu D., Yurter H.

Balkan Journal of Medical Genetics, 13th Balkan Human Genetics Conference, Edirne, Turkey, 17 - 20 April 2020, (Unpublished)

17. Dysregulations of microtubule plus end protein EB3 in spinal muscular atrophy.

Koyunoğlu D., Bora G., Son Ç. D., Yurter H.

2nd International Scientific Congress of Spinal Muscular Atrophy, 5 - 07 February 2020, (Unpublished)

18. End-binding 3 protein alterations in an in vitro spinal muscular atrophy model

Koyunoğlı D., Bora G., Yurter H., Son Ç. D.

7th International Congress of Molecular Biology Association of Turkey, İstanbul, Turkey, 27 - 29 September 2019, (Unpublished)

19. MAP1B upregulation and its involvement of microtubule stability in spinal muscular atrophy.

Bora G., Hensel N., Rademacher S., Koyunoğlu D., Sunguroğlu M., Aksu Mengeş E., et al.

44th FEBS Congress, Krakow, Poland, 6 - 11 July 2019, pp.2-18, (Full Text)

20. MAP1B causes alterations in alpha tubulin detyrosination and microtubule stability in Spinal Muscular Atrophy

Bora G., Koyunoğlu D., Sunguroğlu M., Yurter H.

BAU International Molecular Medicine Symposium by the Bosphorus, İstanbul, Turkey, 16 - 18 May 2019, (Unpublished)

21. Aril Bütanoik Asit Türevlerinin Sınıf I Histon Deasetilaz Enzim İnhibisyon Aktivitelerinin Araştırılması.

Bora G., Sarı S., Taşkor G., Dalkara S., Yurter H.

7. Uluslararası İlaç Kimyası Kongresi, Antalya, Turkey, 14 - 17 March 2019, (Unpublished)

22. Spinal Müsküler Atrofi Patomekanizmasında MAP1B Disregülasyonunun Rolü.

Bora G., Yurter H., Hensel N., Rademacher S., Claus P.

1. Ulusal Nöromüsküler Hastalıklar Kongresi, Ankara, Turkey, 18 - 20 May 2017, (Unpublished)

23. Low SMN Level Causes Alterations in Alpha Tubulin Detyrosination and Microtubule-associated protein 1B in Spinal Muscular Atrophy

Bora G., Rademacher S., Hensel N., Yurter H., Hayta B., Aksu Mengeş E., et al.

FEBS Advanced Lecture Course and 33rd European Cytoskeletal Forum Meeting on “Biology and pathology of cytoskeleton: the crossroads of three cytoskeletal systems., Praha, Czech Republic, 20 - 24 October 2018, (Unpublished)

24. SMN Deficiency Causes Upregulation of Microtubule Associated Protein 1B (MAP1) in Models of Spinal Muscular Atrophy (SMA)

Bora G., Rademacher S., Hensel N., Koyunoğlu D., Claus P., Yurter H.

13th Meeting of the Mediterrranean Society of Myology and 2nd Congress of Turkish Neuromuscular Society, Nevşehir, Turkey, 27 - 29 June 2018, (Unpublished)

25. Metalloprotease-mediated cleavage of the Semaphorin receptor PlexinD1 and its sequestration to actin-cofilin rods in Spinal muscular atrophy (SMA).

Rademacher ., Im W., Verheijen B. M., Hensel N., Miriam P., Bora G., et al.

Brainswick Symposium “Actin Dynamics in Health and Disease in CNS'', Braunschweig, Germany, 16 - 17 October 2017, (Unpublished)

26. Low levels of SMN cause alterations in microtubule associated protein 1b

BORA G., Rademacher S., YEŞBEK KAYMAZ A., Hensel N., KURT C. E., ERDEM ÖZDAMAR S., et al.

21th Annual Spinal Muscular Atrophy Researcher Meeting, Orlando, United States Of America, 29 June - 02 July 2017, (Summary Text)

27. Low levels of SMN cause alterations in microtubule-associated protein 1B.

Bora G., Rademacher S., Yeşbek Kaymaz A., Hensel N., Kurt C. E., Özdamar Erdem S., et al.

21th Cure SMA Researcher Meeting, Florida, United States Of America, 29 June - 03 July 2017, (Unpublished)

28. Serum IGF1 and IGFBP3 levels in SMA patients

Yeşbek Kaymaz A., Köstel Bal S., Bora G., Özön Z. A., Alikaşifoğlu A., Topaloğlu H. A., et al.

21 st World Muscle Society, Granada, Spain, 4 - 08 October 2016, (Summary Text)

29. Serum IGF1 and IGFBP3 levels in SMA patients

Yeşbek Kaymaz A., Bal A. S., Bora G., Alev O., Alikasifoglu ., Topaloglu H., et al.

21st International WMS Congress, Granada, Spain, 4 - 08 October 2016, (Unpublished)

30. Microtubule-associated protein 1B is dysregulated in Spinal Muscular Atrophy.

Bora G., Rademacher S., Hensel N., Claus P., Yurter H.

41th FEBS Conference, Aydın, Turkey, 3 - 08 September 2016, (Unpublished)

31. Effects of exercise training in spinal muscular atrophy type II patients

BORA TATAR G., SUBAŞI Ş., YEŞBEK KAYMAZ A., Tunca Yılmaz Ö., TOPALOĞLU H. A., KARADUMAN A. A., et al.

19th Annual Spinal Muscular Atrophy Researcher Meeting, Kansas, United States Of America, 18 June 2015 - 20 June 2016, (Summary Text)

32. IGF System Elements in SMA Patients

YEŞBEK KAYMAZ A., Köstel Bal S., BORA G., ÖZÖN Z. A., ALİKAŞİFOĞLU A., TOPALOĞLU H. A., et al.

20th Annual Spinal Muscular Atrophy Researcher Meeting, Anaheim, United States Of America, 16 - 19 June 2016, (Summary Text)

33. The Semaphorin receptor PlexinD1 localises to actin rods in Spinal Muscular Atrophy.

Rademacher S., Hensel N., Bora G., Claus P.

20th Annual CureSMA Researcher Meeting, California, United States Of America, 16 - 18 June 2016, (Unpublished)

34. Phosphatase and tensin homologue (PTEN) dephosphorylates the Spinal Muscular Atrophy determining gene product SMN.

Rademacher S., Hensel N., Bora G., Claus P.

20th Annual CureSMA Researcher Meeting., California, United States Of America, 16 - 18 June 2016, (Unpublished)

35. Skeletal muscle expression of insulin like growth factor system elements in spinal muscular atrophy patients

YEŞBEK KAYMAZ A., TALİM B., BORA G., YURTER H.

5th International Congress of Myology, Lyon, France, 14 - 18 March 2016, (Summary Text)

36. Spinal müsküler atrofi hastalarının iskelet kasında insülin benzeri büyüme faktörleri ve bağlayıcı protein düzeylerinin araştırılması

Yeşbek Kaymaz A., Bora G., Yurter H., Talim B.

XIV. Ulusal Tibbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, (Unpublished)

37. Effects of exercise training in spinal muscular atrophy type 2 patients

Bora Tatar G., Subaşı Ş., Yeşbek Kaymaz A., Yılmaz Ö., Topaloğlu H. A., Karaduman A. A., et al.

19th Annual Spinal Muscular Atrophy Researcher Meeting, Kansas, United States Of America, 18 - 20 June 2015, (Unpublished)

38. Spinal müsküler atrofi hastalarının iskeletkasında insulin benzeri büyüme faktörleri ve bağlayıcı protein düzeylerinin araştırılması

YEŞBEK KAYMAZ A., TALİM B., BORA TATAR G., YURTER H.

XIV. Ulusal Tıbbi Biyoloji ve Genetik kongresi, Fethiye, Turkey, 27 October 2015 - 30 October 2014, (Summary Text)

39. Curcumin and Neurite Outgrowth: Investigations for Spinal Muscular Atrophy

Bora G., Yurter H.

FEBS/EMBO Conference, Paris, France, 30 August - 04 September 2014, (Unpublished)

40. RNA İnterferans Optimizasyon Çalışmaları: PC12 Hücre Hattında Gapdh Gen İfadesinin siRNA-Aracılığıyla Baskılanması

Bora G., Yurter H.

XII. Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 27 - 30 October 2011, (Unpublished)

41. Phenolic compounds and their effects on full length and delta 7 SMN2 transcripts

Dayangaç Erden D., Bora G., Dalkara S., Yurter H.

16th International WMS Congress, Algueirao-Mem Martins, Portugal, 18 - 22 October 2011, (Unpublished)

42. SMN2 Gene Expression Studies by Using HDAC Inhibitors

Bora G., Yurter H.

SMA UK Researchers’ Conference, London, United Kingdom, 3 - 04 October 2011, (Unpublished)

43. The effects on SMN2 gene expression.

Bora G., Uzunallı G., Dayangaç Erden D., Yurter H.

14th Annual International Spinal Muscular Atophy Research Group Meeting , California, United States Of America, 24 - 26 June 2010, (Unpublished)

44. Spinal Muscular Atrophy: Oxidative Stress Modulating the Pathogenesis?

Köstel A. S., Bora G., Yurter H.

4th ESF Conferences on Functional Genomics and Disease, Dresden, Germany, 14 - 17 April 2010, (Unpublished)

45. Histone Deacetylase Inhibition Activities of Rosmarinic acid and quercetin.

Bora G.

3rd BBBB-Bosphorus International Conference on Pharmaceutical Sciences. , Antalya, Turkey, 26 - 28 October 2009, (Unpublished)

46. Resveratrol increases SMN2 gene expression in spinal muscular atrophy.

Yurter H., Dayangaç Erden D., Uzunallı G., Bora G., P A., Dalkara S., et al.

12th Annual International Spinal Muscular Atophy Research Group Meeting , Massachusetts, United States Of America, 11 - 14 June 2008, (Unpublished)

47. Vitamin D receptor polymorphisms and vitamin D deficient rickets in Turkey.

Bora G., Özkan B., Dayangaç Erden D., Yurter H., Coşkun T.

European Human Genetics Conference, Barcelona, Spain, 31 May - 03 June 2008, (Unpublished)

48. Histone deacetylase inhibition activity of resveratrol and its analogs.

Dayangaç Erden D., Bora G., Peruze A., Yelekçi K., Dalkara S., Sıtkı D. A., et al.

American Chemical Society 234th National Meeting & Exposition, Massachusetts, United States Of America, 19 - 23 August 2007, (Unpublished)

49. The investigations of histone deacetylase inhibitors for treatment of SMA.

Yurter H., Dayangaç Erden D., Bora G., Topaloğlu H.

International Spinal Muscular Atrophy Research Group Meeting, Montreal, Canada, 10 - 12 July 2006, (Unpublished)

Books 2

1. Hücre İskeleti

BORA AKOĞLU G., PEYNİRCİOĞLU B.

in: İnsan Moleküler Biyolojisi., Hayat Erdem Yurter, Asuman Sunguroğlu, Sena Aydos, Fatma Belgin Ataç, Editor, Hipokrat, Ankara, pp.299-312, 2023

2. Model organizmalar ve hastalık modelleme (Bölüm 21)

BORA G.

in: İnsan Moleküler Genetiği (Human Molecular Genetics-Çeviri), Prof. Dr. Pervin Dinçer, Editor, Hipokrat, pp.667-692, 2020

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

272

H-Index (WoS)

Citation (Scopus)

394

H-Index (Scopus)

Citation (Sobiad)

H-Index (Sobiad)

Project

Intellectual Property

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Sobiad)

H-Index (Sobiad)

Project

Intellectual Property

Thesis Advisory

Open Access